Inir 10mg, 18mg, 25mg, 40mg, 60mg Capsule

Inir 10mg, 18mg, 25mg, 40mg, 60mg Capsule

S5
PDF Leaflet Revision Date: 25 November 2016


Clinical Summary

Quick overview from the medicine insert

Indication

Treatment of ADHD in children 6 years and older, adolescents, and adults.

Dosage (summary)

Children <70 kg: 0.5 mg/kg, maintenance 1.2 mg/kg/day; Adults: Initiate at 40 mg, maintenance 80 mg.

Onset of Action / Duration

Onset: 1-2 hours, Duration: Not specified.

Special Populations

  • Hepatic impairment
  • End-stage renal disease

Pregnancy & Breastfeeding

No adequate studies in pregnancy; unknown if excreted in human milk.

Key Drug Interactions

  • MAOIs
  • Beta-adrenergic agonists
  • CYP2D6 inhibitors

Contraindications

  • Hypersensitivity to atomoxetine
  • Uncontrolled hypertension
  • Narrow angle glaucoma

Common side effects

  • Decreased appetite
  • Suicidal ideation
  • Mood swings
  • Dizziness
  • Palpitations

Counselling Points

  • Monitor for mood changes
  • Use caution when driving
  • Do not open capsules
  • Report jaundice or liver symptoms

Serious warnings

  • Risk of suicidal behavior
  • Liver injury
  • Mood swings
  • Cardiovascular effects

Only Available on the App

To ensure the fastest, most secure experience, this feature is exclusively available on the free Medinsert mobile app.

Download the App. Its Free!
On This Page
Inir 10mg, 18mg, 25mg, 40mg, 60mg Capsule
1/-
Loading package insert…

Medinsert AI

Hello! I am Medinsert Ai. What would you like to know about this professional information leaftleft?
App Icon

Medinsert Mobile App

3000+ Package Inserts on the go.

VIEW